The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease.
about
Gastroesophageal reflux disease: medical or surgical treatment?Systematic review: pathophysiology and management of gastrointestinal dysmotility in systemic sclerosis (scleroderma).Functional heartburn: the stimulus, the pain, and the brainReview article: new pharmacological agents for the treatment of gastro-oesophageal reflux disease.Prokinetics in the Management of Functional Gastrointestinal Disorders.Review article: gastro-oesophageal reflux disease as a functional gastrointestinal disorder.Updated guidelines for the diagnosis and treatment of gastroesophageal reflux disease.Systematic review: proton-pump inhibitor failure in gastro-oesophageal reflux disease--where next?Pharmacological targets in gastro-oesophageal reflux disease.An update on the available treatments for non-erosive reflux disease.Refractory heartburn to proton pump inhibitors: epidemiology, etiology and management.Mechanisms of serotonergic agents for treatment of gastrointestinal motility and functional bowel disorders.Effects of prucalopride on esophageal secondary peristalsis in humans.Barrett's esophagus: proton pump inhibitors and chemoprevention I.Effects of mosapride on esophageal functions and gastroesophageal reflux.Effect of cisapride on nocturnal transient lower oesophageal sphincter relaxations and nocturnal gastro-oesophageal reflux in patients with oesophagitis: a double-blind, placebo-controlled study.
P2860
Q33580756-CA5B92F6-B225-4906-A234-396A707F9254Q34504541-B9758233-8C3C-40D2-BFBD-0C3C79960B87Q34994672-41A494A1-34DE-47E8-8FC9-14364A5DFC6EQ35772657-606F856C-CC6D-4AC4-882C-DD1DD737FCEBQ35834499-DC8FD474-174A-4651-9529-4D703CAEEBFFQ35936961-35A59B57-976C-4A38-A3FF-B8B7A7C9AF3CQ36011773-81F2C8C5-EC39-448F-8F72-96C6BF2FABF9Q36191254-FD96FF3D-949A-4BFD-9916-9A985DA18832Q36346427-2EA2B724-8713-4AD4-B3C8-1893865A3131Q36349598-636A8752-C42C-4E82-9E2E-136C850241F8Q36554323-985EE25D-CE7E-43F4-A9FC-7391A968D32DQ36874388-405C59C7-35AE-4292-80B9-441CAFA56036Q37620320-7BF96D90-86B4-4F69-B9B8-4890CEEF4773Q37939281-29C2C6C8-4B20-44EB-98EF-D2A0B05398ADQ42995641-5BD0412D-9F3F-4DC2-A429-D61F22861270Q43944809-396F26AC-AA93-485E-86FD-411ED83FEB56
P2860
The effects of tegaserod (HTF 919) on oesophageal acid exposure in gastro-oesophageal reflux disease.
description
2000 nî lūn-bûn
@nan
2000年の論文
@ja
2000年学术文章
@wuu
2000年学术文章
@zh
2000年学术文章
@zh-cn
2000年学术文章
@zh-hans
2000年学术文章
@zh-my
2000年学术文章
@zh-sg
2000年學術文章
@yue
2000年學術文章
@zh-hant
name
The effects of tegaserod (HTF ...... ro-oesophageal reflux disease.
@en
The effects of tegaserod
@nl
type
label
The effects of tegaserod (HTF ...... ro-oesophageal reflux disease.
@en
The effects of tegaserod
@nl
prefLabel
The effects of tegaserod (HTF ...... ro-oesophageal reflux disease.
@en
The effects of tegaserod
@nl
P2093
P2860
P1476
The effects of tegaserod (HTF ...... ro-oesophageal reflux disease.
@en
P2093
Castell DO
Kahrilas PJ
Quigley EM
Spechler SJ
P2860
P304
P356
10.1046/J.1365-2036.2000.00854.X
P407
P577
2000-11-01T00:00:00Z